• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物或非生物改善病情抗风湿药治疗是否会改变类风湿关节炎患者的牙周状况?

Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis?

作者信息

Romero-Sanchez Consuelo, Rodríguez C, Santos-Moreno P, Mesa A M, Lafaurie G I, Giraldo-Q S, De-Avila J, Castillo D M, Duran M, Chalem P Ch, Bello Gualtero J M, Valle-Oñate R

机构信息

Universidad El Bosque. Av. Cra 9 No. 131 A - 02, Bogotá, 111121, Colombia.

Unit of Oral Basic Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia.

出版信息

Curr Rheumatol Rev. 2017;13(2):139-151. doi: 10.2174/1573397113666170407161520.

DOI:10.2174/1573397113666170407161520
PMID:28403797
Abstract

BACKGROUND AND OBJECTIVE

Experimental models suggest the use of different therapy protocols in rheumatoid arthritis (RA) as modulators on periodontal condition. This study evaluated the effects of conventional drug treatment and anti-TNF therapy in patients with RA on microbiological and periodontal condition, establishing the association of markers of periodontal infection with indexes of rheumatic activity.

MATERIALS AND METHODS

One hundred seventy nine individuals with RA were evaluated (62 with anti-TNF-. and 115 with only DMARDs). The periodontal evaluation included plaque and gingival indexes, bleeding on probing (BOP), clinical attachment loss (CAL), pocket depth (PD) and subgingival plaque samples for microbiological analysis. Rheumatologic evaluations included a clinical examination, rheumatoid factor (RF), antibodies against cyclic-citrullinated peptides (ACPAs), and activity markers (DAS28-ERS), high sensitive C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR).

RESULTS

Anti-TNF-alpha therapy influenced periodontal microbiota with a higher frequency of T. denticola (p=0.01). Methotrexate combined with leflunomide exhibited a higher extension of CAL (p=0.005), and anti-TNF-alpha therapy with methotrexate was associated with a lower extension of CAL (p=0.05). The use of corticosteroids exerted a protective effect on the number of teeth (p=0.027). The type of DMARD affected P. gingivalis, T. forsythia and E. nodatum presence. Elevated ACPAs titers were associated with the presence of red complex periodontal pathogens (p=0.025). Bleeding on probing was associated with elevated CPR levels (p=0.05), and ESR was associated with a greater PD (p=0.044) and presence of red complex (p=0.030).

CONCLUSION

Different pharmacological treatments for RA affect the clinical condition and subgingival microbiota.

摘要

背景与目的

实验模型表明,在类风湿关节炎(RA)中使用不同的治疗方案可作为牙周状况的调节因子。本研究评估了RA患者接受传统药物治疗和抗TNF治疗对微生物学和牙周状况的影响,确定了牙周感染标志物与风湿活动指标之间的关联。

材料与方法

对179例RA患者进行了评估(62例接受抗TNF-α治疗,115例仅接受改善病情抗风湿药治疗)。牙周评估包括菌斑和牙龈指数、探诊出血(BOP)、临床附着丧失(CAL)、牙周袋深度(PD)以及用于微生物分析的龈下菌斑样本。风湿学评估包括临床检查、类风湿因子(RF)、抗环瓜氨酸肽抗体(ACPA)以及活动标志物(DAS28-ERS)、高敏C反应蛋白(hs-CRP)、红细胞沉降率(ESR)。

结果

抗TNF-α治疗影响牙周微生物群,具核梭杆菌的检出频率更高(p=0.01)。甲氨蝶呤联合来氟米特导致CAL扩展程度更高(p=0.005),而抗TNF-α治疗联合甲氨蝶呤与较低的CAL扩展程度相关(p=0.05)。使用皮质类固醇对牙齿数量有保护作用(p=0.027)。改善病情抗风湿药的类型影响牙龈卟啉单胞菌、福赛坦氏菌和具核梭杆菌的存在情况。ACPA滴度升高与红色复合体牙周病原体的存在相关(p=0.025)。探诊出血与CPR水平升高相关(p=0.05),ESR与更大的PD(p=0.044)以及红色复合体的存在相关(p=0.030)。

结论

RA的不同药物治疗会影响临床状况和龈下微生物群。

相似文献

1
Is the Treatment with Biological or Non-biological DMARDS a Modifier of Periodontal Condition in Patients with Rheumatoid Arthritis?生物或非生物改善病情抗风湿药治疗是否会改变类风湿关节炎患者的牙周状况?
Curr Rheumatol Rev. 2017;13(2):139-151. doi: 10.2174/1573397113666170407161520.
2
Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.慢性牙周病妨碍类风湿关节炎患者对抗肿瘤坏死因子治疗的反应。
J Clin Rheumatol. 2012 Jun;18(4):180-4. doi: 10.1097/RHU.0b013e31825828be.
3
Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.类风湿关节炎患者的抗肿瘤坏死因子-α治疗与牙周参数
J Periodontol. 2009 Sep;80(9):1414-20. doi: 10.1902/jop.2009.090015.
4
Association of different immunosuppressive medications with periodontal condition in patients with rheumatoid arthritis: Results from a cross-sectional study.类风湿关节炎患者不同免疫抑制剂药物与牙周状况的相关性:一项横断面研究的结果。
J Periodontol. 2018 Nov;89(11):1310-1317. doi: 10.1002/JPER.17-0616. Epub 2018 Aug 23.
5
Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients.抗风湿治疗对类风湿关节炎患者牙周状况的影响。
Int J Environ Res Public Health. 2021 Mar 4;18(5):2529. doi: 10.3390/ijerph18052529.
6
Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.牙周治疗可降低接受或未接受肿瘤坏死因子抑制剂治疗的患者中活动性类风湿关节炎的严重程度。
J Periodontol. 2009 Apr;80(4):535-40. doi: 10.1902/jop.2009.080447.
7
Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis.强直性脊柱炎患者抗 TNF 治疗的牙周炎反应。
J Clin Rheumatol. 2015 Oct;21(7):341-5. doi: 10.1097/RHU.0000000000000300.
8
Periodontal Disease in Individuals With a Genetic Risk of Developing Arthritis and Early Rheumatoid Arthritis: A Cross-Sectional Study.具有患关节炎和早期类风湿关节炎遗传风险个体的牙周病:一项横断面研究。
J Periodontol. 2016 Apr;87(4):346-56. doi: 10.1902/jop.2015.150455. Epub 2015 Nov 26.
9
The role of risk factors for periodontal disease in patients with rheumatoid arthritis.类风湿关节炎患者牙周病危险因素的作用。
Eur J Med Res. 1998 Aug 18;3(8):387-92.
10
Influence of anti-rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta-analysis.抗风湿药物对类风湿关节炎合并牙周炎患者牙周状况的影响:系统评价和荟萃分析。
J Periodontal Res. 2021 Dec;56(6):1099-1115. doi: 10.1111/jre.12925. Epub 2021 Sep 12.

引用本文的文献

1
Does non-surgical periodontal treatment contribute to rheumatoid arthritis amelioration? Evidence based on an overview and meta-analysis.非手术牙周治疗对类风湿性关节炎的改善有帮助吗?基于综述和荟萃分析的证据。
Odontology. 2025 Jul;113(3):903-917. doi: 10.1007/s10266-024-01033-w. Epub 2024 Nov 29.
2
Hypochlorous Acid as a Potential Postsurgical Antimicrobial Agent in Periodontitis: A Randomized, Controlled, Non-Inferiority Trial.次氯酸作为牙周炎术后潜在抗菌剂的随机对照非劣效性试验
Antibiotics (Basel). 2023 Aug 12;12(8):1311. doi: 10.3390/antibiotics12081311.
3
New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis.
炎症性破骨细胞前体作为类风湿性关节炎和牙周炎治疗靶点的新见解。
Bone Res. 2023 May 22;11(1):26. doi: 10.1038/s41413-023-00257-w.
4
The Interaction Effect of Anti-RgpA and Anti-PPAD Antibody Titers: An Indicator for Rheumatoid Arthritis Diagnosis.抗RgpA和抗PPAD抗体滴度的相互作用效应:类风湿性关节炎诊断的一个指标
J Clin Med. 2023 Apr 21;12(8):3027. doi: 10.3390/jcm12083027.
5
Differential analysis of culturable and unculturable subgingival target microorganisms according to the stages of periodontitis.根据牙周炎的阶段对可培养和不可培养龈下目标微生物进行差异分析。
Clin Oral Investig. 2023 Jun;27(6):3029-3043. doi: 10.1007/s00784-023-04907-5. Epub 2023 Feb 18.
6
Oral manifestations associated with inflammatory bowel disease and early endoscopic findings in patients with spondyloarthritis.炎症性肠病相关的口腔表现和脊柱关节炎患者的早期内镜表现。
BMC Oral Health. 2022 Nov 9;22(1):477. doi: 10.1186/s12903-022-02497-4.
7
Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota.甲氨蝶呤促进关节炎引起的牙槽骨丢失的恢复,并改变口腔-肠道微生物组的组成。
Anaerobe. 2022 Jun;75:102577. doi: 10.1016/j.anaerobe.2022.102577. Epub 2022 Apr 28.
8
Healthcare Professionals' Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients.医疗保健专业人员对类风湿关节炎患者使用生物疾病修正抗风湿药物的标准管理指南的遵从情况。
Int J Environ Res Public Health. 2022 Apr 13;19(8):4699. doi: 10.3390/ijerph19084699.
9
Role of Interleukin-17A in the Pathomechanisms of Periodontitis and Related Systemic Chronic Inflammatory Diseases.白细胞介素-17A 在牙周炎及相关系统性慢性炎症性疾病发病机制中的作用。
Front Immunol. 2022 Mar 17;13:862415. doi: 10.3389/fimmu.2022.862415. eCollection 2022.
10
The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review.公认和新型抗风湿疗法对牙周组织的影响——一篇叙述性综述
Pharmaceuticals (Basel). 2021 Nov 23;14(12):1209. doi: 10.3390/ph14121209.